Skip to content

PTSD research published in 2022

Page 5 of 5: studies 81 to 87 of 87, newest first. Back to the PTSD overview

Studies

Dreams and nightmares during the pandemic.

Somnologie: Schlafforschung und Schlafmedizin 2022 Severin Ableidinger, Franziska Nierwetberg, Brigitte Holzinger

The pandemic caused by the coronavirus disease 2019 (COVID-19) had a huge impact on public mental health. This was also reflected in dreams. Not only did people start to remember more dreams, but dream content changed as themes like sickness, confinement, and-in the English-speaking world-even bugs began to dominate. This also led to an increase in nightmare frequency. There are various factors...

Post-traumatic stress disorder, suggestibility, and dissociation related to alleged alien abductions.

Explore 2022 José I Latorre, María Y Vellisca

Thousands of people throughout the world are convinced that they have been abducted by aliens. We aimed to assess the emotional reaction to such an implausible event and propose some explanations alternative to severe psychopathology. A total of 19 individuals who reported memories of having been abducted by aliens were compared to a control group of 32 participants. We employed a battery of...

Valued living among veterans in breath-based meditation treatment or cognitive processing therapy for posttraumatic stress disorder: Exploratory outcome of a randomized controlled trial

Global Advances in Health and Medicine 2022 R. J. Schulz-Heik, Laura C. Lazzeroni, Beatriz Hernandez et al.

Background Valued living is the extent to which an individual’s behavior is consistent with what they believe is important or good. It is unknown whether many complementary and integrative treatments and psychotherapies for posttraumatic stress disorder enhance valued living, and for whom. Objectives Measure within- and between-group changes in valued living in Veterans who completed cognitive...

Corrigendum: A cohort-based case report: The impact of ketamine-assisted therapy embedded in a community of practice framework for healthcare providers with PTSD and depression.

Frontiers in Psychiatry 2022 Shannon Dames, Pamela Kryskow, Crosbie Watler correction

Corrigendum: A Cohort-Based Case Report: The Impact of Ketamine-Assisted Therapy Embedded in a Community of Practice Framework for Healthcare Providers with PTSD and DepressionError in Figure/TableIn the published article, there was an error in Figure 2 as published. The PTSD label on the legend that is imbedded in the figure was on the legend component of the figure was posted on the anxiety...

Case report: Medical student types journals during ketamine infusions for suicidal ideation, treatment-resistant depression, post-traumatic stress disorder, and generalized anxiety disorder.

Frontiers in Psychiatry 2022 Joshua Willms, Ben McCauley, Lindsay Kerr et al.

Suicide is the most common cause of death in male resident physicians and the second most common cause of death in resident physicians overall. Physicians also experience high rates of major depressive disorder (MDD), post-traumatic stress disorder (PTSD), and burnout. These conditions frequently develop during medical school, and threaten not only physicians but the patients they care for. A...

DOI: 10.3389/fpsyt.2022.1020214 (opens in new tab) Full text (opens in new tab) Depression Ketamine assisted psychotherapy Medical school Suicidality

Assessment of clinical outcomes in patients with post-traumatic stress disorder: analysis from the UK Medical Cannabis Registry.

Expert Review of Neurotherapeutics 2022 Manaswini Pillai, Simon Erridge, Lara Bapir et al. 27 citations

The current paucity of clinical evidence limits the use of cannabis-based medicinal products (CBMPs) in post-traumatic stress disorder (PTSD). This study investigates health-related quality of life (HRQoL) changes and adverse events in patients prescribed CBMPs for PTSD. A case-series of patients from the UK Medical Cannabis Registry was analyzed. HRQoL was assessed at 1-, 3-, and 6-months...

Altered brain activity and functional connectivity after MDMA-assisted therapy for post-traumatic stress disorder.

Frontiers in Psychiatry 2022 S Parker Singleton, Julie B. Wang, Michael C Mithoefer et al. 36 citations

3,4-methylenedioxymethamphetamine-assisted therapy (MDMA-AT) for post-traumatic stress disorder (PTSD) has demonstrated promise in multiple clinical trials. MDMA is hypothesized to facilitate the therapeutic process, in part, by decreasing fear response during fear memory processing while increasing extinction learning. The acute administration of MDMA in healthy controls modifies recruitment...

DOI: 10.3389/fpsyt.2022.947622 (opens in new tab) Full text (opens in new tab) Amygdala FMRI Functional connectivity Hippocampus +9